Cargando…
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD), which is characterized by lethal degeneration of cardiac and skeletal muscles. Mutations that delete exon 44 of the dystrophin gene represent one of the most common causes of DMD and can be corrected in ~12% of patients by edi...
Autores principales: | Min, Yi-Li, Li, Hui, Rodriguez-Caycedo, Cristina, Mireault, Alex A., Huang, Jian, Shelton, John M., McAnally, John R., Amoasii, Leonela, Mammen, Pradeep P. A., Bassel-Duby, Rhonda, Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402849/ https://www.ncbi.nlm.nih.gov/pubmed/30854433 http://dx.doi.org/10.1126/sciadv.aav4324 |
Ejemplares similares
-
In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
por: Amoasii, Leonela, et al.
Publicado: (2019) -
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
por: Zhang, Yu, et al.
Publicado: (2022) -
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
por: Chemello, F., et al.
Publicado: (2021) -
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
por: Zhang, Yu, et al.
Publicado: (2020) -
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
por: Zhang, Yu, et al.
Publicado: (2017)